Unbound MEDLINE

A Case of Topiramate-Induced Epistaxis. Current drug safety [Curr Drug Saf] Journal article

 
TitleA Case of Topiramate-Induced Epistaxis.
Author(s)Polimeni G, Grugno R, Vitetta A, Cordici F, Alagna A, Caputi AP, Bramanti P 
InstitutionIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Centro Neurolesi "Bonino-Pulejo", S.S. 113, Via Palermo, C.da Casazza, 98124, Messina - Italy. gpolimeni@unime.it.
SourceCurr Drug Saf 2009 Sep 1.
AbstractThe current case describes epistaxis in a patient treated with a daily regimen of topiramate 100mg for migraine. The patient had not a past medical history of nosebleeds and laboratory parameters were within normal ranges. She was then advised to withdraw topiramate, and the epistaxis resolved within 12 hours after its discontinuation. Since then, the patient never complained other blood clotting disorders. The potential antiplatelet activity of topiramate is discussed.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19534643
  
Advertise on this site.